🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7371572

Mouse titers after two immunizations with VLPs alone

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371385

Method of treating immune pathologies with low dose estrogen

Government of the United states of America dba The Department of Veterans Affairs · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371392

Cd40 ligand adjuvant for respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371821

Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be

United States of America as represented by the Secretary of the Air Force · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368114

Fusion protein including of CD4

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368116

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368110

Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368100

Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and me

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365171

Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities

Beijing Medical University United Biological Engineering Company · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7364719

Vasoregulating compounds and methods of their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361664

Vitamin D receptor antagonists and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7358377

Schweinfurthin analogues

The United States of America · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7355012

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354909

Method for rapid generation of mature dendritic cells

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354904

Bacteriocin inducer peptides

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354711

Methods for inhibiting immunostimulatory DNA associated responses

The Department of Veterans Affairs, as represented by the Secretary of United States of America · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7351435

Deglycosylated ricin toxin a-chain vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7351403

Sunscreen reagents from unsaturated waxes and triglycerides

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348319

Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7341726

Modified HCV peptide immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7338807

Screening assays for compounds that cause apoptosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted